CD4 and neoplasm: Notably, a large increase in CD4+ T lymphocytes was observed for tumour T4 (25.7% to 76.8%) and in CD8+ T lymphocytes in tumours T2 (4.5% to 21.4%) and T3 (2.7% to 11.9%).